Meritain Health policies
Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
7 policies name S2140, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 1032-Omidubicel-onlv (Omisirge) | 1032 · Commercial | 9 | Original policy ↗ |
| Hematopoietic Cell Transplantation for Autoimmune Diseases and Miscellaneous Indications | 0606 · Commercial | 19 | Original policy ↗ |
| 1099-Narsoplimab-wuug (Yartemlea) | 1099 · Commercial | 25 | Original policy ↗ |
| Stem Cells for Hematopoietic Cell Transplant | 0190 · Commercial | 29 | Original policy ↗ |
| 0195-Erythropoesis Stimulating Agents | 0195 · Commercial | 32 | Original policy ↗ |
| Pegzilarginase-nbln (Loargys) | 1101 · Commercial | 35 | Original policy ↗ |
| 0765-Age-related Macular Degeneration | 0765 · Commercial | 47 | Original policy ↗ |